oral semaglutide phase 3 FDA Approves First GLP-1 Drug Eli Lilly's Oral GLP-1 Pill

Of the study population, 61% had type 2 diabetes and the rest did not

Notably, 65.3% of participants taking retatrutide 12 mg achieved a BMI 22 at Week 80

Non-active duty beneficiaries may also use MTF pharmacies and may pay a reduced copay

Data were analyzed using the non-parametric Kruskal-Wallis test, with Bonferronis post-hoc test in case of significance

But the growth of the category is itself a market verdict: a meaningful share of patients has concluded that predictable self-pay with clinical oversight beats unpredictable coverage, and the KFF finding that about 27 percent of GLP-1 users pay fully out of pocket despite holding insurance suggests many were effectively self-pay already, just without the transparency